Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > # 1 on bullboards today
View:
Comment by chry200030 on Dec 21, 2024 6:54pm
This is about to get interesting.  We could see $2 in 2025 and a double each year going forward  until a buyout. All eyes wll be on TLT for a while..
Comment by Infinity on Dec 21, 2024 8:07pm
We are not going anywhere, will be treading water till we get the BTD.  I am hoping that TLT has applied for it already.  IMO BTD will be the Catalyst to move and be seen by the Big Boys
Comment by patience69 on Dec 21, 2024 9:16pm
Of course you do realize that we could get AA or even full approval without BTD?
Comment by menoalittle on Dec 21, 2024 11:07pm
There's a way of looking at the data that probably makes Ruvidar more likely to receive AA than BTD... but I'm not thinking or saying it would be before BTD.  Just, more likely when they eventually do apply for it. (Hopefully sooner in 2025 rather than later in 2025.) 
Comment by bmk211 on Dec 21, 2024 11:14pm
Without BTD, AA.   would we be required for a phase 3 trial?
Comment by enriquesuave on Dec 21, 2024 11:51pm
No PH3.  Would have to wait for entire data set on 85-100 patients and aim for full standard approval. End of 2026-early 2027.  That's the worst case scenario ( other than no approval)but would still end up  to be amazing!    
Comment by menoalittle on Dec 21, 2024 11:59pm
I don't believe you have that right, enriquesuave.  My understanding is they aren't actually that far away from having what they need to apply for AA, and are aiming to do so sometime in 2025.
Comment by enriquesuave on Dec 22, 2024 12:19am
I agree.  I was just responding to bmk.  If we don't get BTD or AA, unlikely IMO, but possible, then we would still not have to do a PH3 but would have to complete PH2 for full approval.    
Comment by Infinity on Dec 22, 2024 1:22am
bmk,  you have a valid question.  I truly believe no one on this board can answer that question unless he/she have insider information.  IMO FDA is biased and the odds favour the BIG Pharma.  We  are just a pest  trying to share more of the Big Pharma PIE!!.  
Comment by Infinity on Dec 22, 2024 1:35am
Just take one example of Theranos. FDA approved them.  Try and convince me they are unbiased.  Here is more information on Theranos.  Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014. The company claimed that it had devised blood tests that required very small ...more  
Comment by Longholder99 on Dec 22, 2024 10:37am
Infinity are you suggesting that Theralase has misled its investors and the FDA by presenting false data for consideration for approval much the same as Theranos did?  A very serious allegation and I hope supportable with factual information if those is your point? 
Comment by Kingpin68 on Dec 22, 2024 12:53pm
I think the point on Theranos is that the FDA got duped big time. How? Some form of bias in their assessment? That was only about 10 years ago, and quite an embarrassment for the FDA.
Comment by Kingpin68 on Dec 22, 2024 1:19pm
Actually, FDA only approved one finger stick test for Herpes. Nothing else was FDA approved. I should have done a simple search before taking Infinity info at face value ...
Comment by Longholder99 on Dec 22, 2024 2:46pm
Not too many bashers have much more than rhetorical scare tactics too post here.  If you've been around long, or can read, you can label their submissions for what they are fairly quick.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250